BioStock: PHI part of new regenerative medicine alliance

Swedish medtech company Phase Holographic Imaging (PHI) have created a technology development alliance with key industry players: Wake Forest Institute for Regenerative Medicine, BioSpherix, QIAGEN and global analytics company SAS. By creating the AI-based process control tools needed for automated biomanufacturing, cell-based therapies could be manufactured cost-effectively with optimised efficacy and safety. BioStock reached out to PHI's Product Manager Lisa Lindström to learn more.

Read the full interview with Lisa Lindström at biostock.se:

https://www.biostock.se/en/2022/11/phi-part-of-new-regenerative-medicine-alliance/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/